Inside Intestinal Disease
Sheena Cruickshank explains how examining gut mucus microbiota can lead to earlier diagnosis – or even prediction – of inflammatory bowel disease
Sheena Cruickshank |
Inflammatory bowel diseases (IBD) are relapsing and remitting chronic conditions of the gut that have a major impact on patients’ quality of life. Current therapeutic approaches aim to reduce symptoms – but their effectiveness varies, and patients may develop tolerances to the drugs. As such, it’s really important to have ways of assessing disease activity to better manage patients. Identifying microbial alterations associated with IBD could provide a diagnostic tool that enables us to spot disease earlier and minimize damage. It also contributes to better understanding of the underlying mechanisms associated with disease pathogenesis, allowing the design of improved therapeutic strategies.
Read the full article now
Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Pathologist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.